Almirall : International experts elaborate a consensus on the effects, present and potential medical utilities of cannabinoid based therapy | 4-Traders

Over the last couple of decades there has been a significant growth in research efforts involving the human endocannabinoid (eCB) system, and experts have come a long way in identifying the cannabinoid human receptors, the internal molecules that interact with them and their possible changes in diseases. A panel of cannabinoids international experts have recently elaborated the consensus review ‘Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?’ which has been published online in the Expert Review of Clinical pharmacology journal1, sponsored by the pharmaceutical company Almirall.The aim of this consensus article is to review the most relevant scientific information available related to the medicinal use of different cannabinoids (natural or synthetic) for the treatment of human diseases, including tetrahydrocannabinol (THC), cannabidiol (CBD) and a number of other cannabinoids, to reflect the present and also the potential medical utilities of cannabinoid based therapy.

Source: Almirall : International experts elaborate a consensus on the effects, present and potential medical utilities of cannabinoid based therapy | 4-Traders

This site uses Akismet to reduce spam. Learn how your comment data is processed.